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In December 2000, an infectious disease spread through a
captive breeding group of African wild dogs (Lycaon pictus) in
Tanzania, killing 49 of 52 animals within 2 months. The caus-
ative agent was identified as Canine distemper virus (CDV) by
means of histologic examination, virus isolation, reverse tran-
scriptase-polymerase chain reaction analysis, and nucleotide
sequencing. This report emphasizes the importance of ade-
quate protection against infectious diseases for the successful
outcome of captive breeding programs of endangered species.
he African wild dog (Lycaon pictus) is a highly endan-
gered carnivore found in Africa south of the Sahara. Its
population, estimated at <5,500, has declined dramatically in
recent decades. Suggested causes for this decline include habi-
tat loss, killing by humans, reduced prey availability, competi-
tion with other carnivores, and infectious diseases, including
rabies and canine distemper (1).
As part of a conservation plan for the African wild dog, a
captive breeding program was established in 1995 at Mkomazi
Game Reserve, Tanzania, under the auspices of the Govern-
ment of Tanzania. A founder group of 25 animals was divided
into four breeding packs, each housed in a separate fenced
enclosure. The founder members and captive-born pups were
vaccinated against canine distemper with a vaccine success-
fully used in seals (2), rabies (Rabdomun, Schering-Plough
Animal Health, Brussels, Belgium), and parvoviral disease and
leptospirosis (combination vaccine: Dohyvac I-LP, Solvay
Duphar, Weesp, the Netherlands). The vaccination schedule
consisted of three consecutive vaccinations at 2- to 4-week
intervals and annual revaccination, most recently in November
1999. Blood samples from a proportion of the vaccinated ani-
mals were collected at the time of vaccination to monitor
immune response.
 The Outbreak
On December 20, 2000, two of the African wild dogs in
one of the breeding packs became ill from an apparently infec-
tious disease. The disease spread rapidly and was first noted in
the other breeding packs on January 16, 18, and 22, 2001,
respectively. The first deaths occurred on December 21, 2000;
deaths peaked from January 30 to February 6, 2001, when 15
of the wild dogs died. The last death was recorded on February
13, 2001. Forty-nine of the 52 animals died during this out-
break.
Neutralizing antibody levels to Canine distemper virus
(CDV), determined by methods similar to those used in a
study of large felids (3), were measured in serum samples col-
lected from nine African wild dogs on November 8, 2000. One
of the three animals that survived the outbreak had a neutraliz-
ing antibody titer of 20; the other two were not tested. The sera
from the remaining eight animals had a titer of <20, which is
considered to be below the level of protection against canine
distemper (4).
Tissue samples from nine animals that had died were used
for histologic examination (n=6), virus isolation (n=2), and
reverse transcriptase-polymerase chain reaction (RT-PCR)
with Morbillivirus-specific primers P1: 5'ATGTTTATGATCA-
CAGCGGT 3' and P2: 5'ATTGGGTTGCACCACTTGTC 3',
which have been used before for phylogenetic analysis of mor-
billiviruses (5) (n=3). The results of analysis were consistent
for all animals tested. The main histologic lesion was broncho-
interstitial pneumonia with epithelial necrosis and multinucle-
ated syncytial cells. Eosinophilic intracytoplasmic inclusion
bodies, characteristic of canine distemper, were found in the
epithelium of lung, kidney, intestine, and urinary bladder (Fig-
ure 1). Lung samples scored positive by RT-PCR for a Mor-
billivirus P-gene fragment. Phylogenetic analysis of the
nucleotide sequences from the resulting PCR fragments dem-
onstrated that the causative virus was most closely related to
CDV (Figure 2A) and clustered with the sequences of CDV
strains from domestic dogs (Canis familiaris), lions (Panthera
leo), and bat-eared foxes (Otocyon megalotis) from East
Africa in the 1990s (Figure 2B). P-gene fragments of the virus
isolates from lung samples were identical to the sequences of
the PCR products obtained directly from the tissue samples.
 Conclusions
These results show that the primary cause of death of these
African wild dogs was CDV infection. Canine distemper is
highly infectious for many species of carnivores and causes
high death rates in immunologically naïve populations (7). It is
a known cause of death in free-living African wild dogs (8), as
well as other wild carnivores, both free-living and captive
(9,10). Based on phylogenetic analysis, the causative virus
was a CDV strain circulating in the region in the past decade
(11,12) (Figure 2B). 
Potential routes of transmission of this virus to the captive
breeding groups are by direct contact with infected domestic
dogs or wild carnivores or indirectly by contact with humans
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or their equipment. Domestic dog populations in some parts of
Tanzania are endemically infected with CDV and were consid-
ered to be the source of infection for canine distemper in
Serengeti lions in 1994 (13). Domestic dogs were not present
at Mkomazi Game Reserve; however, transmission of CDV
from domestic dogs in neighboring villages cannot be ruled
out.
Because vaccination with live attenuated virus had been
suspected of causing past deaths of African wild dogs (14,15)
the animals in this breeding program were vaccinated with a
CDV-ISCOM vaccine, which does not contain live virus. This
vaccine protects harbor seals (Phoca vitulina) and dogs against
phocine distemper virus infection (2), which is closely related
to CDV, and resulted in protective antibody levels to CDV in
African wild dogs monitored at the beginning of this captive
breeding program (data not shown). However, the lack of neu-
tralizing antibody titers to CDV in sera of these African wild
dogs from November 2000 and the high death rate from canine
distemper despite recent vaccination indicate vaccination fail-
ure. We are investigating possible reasons for this failure,
including problems with application, maintenance of the cold
chain, efficacy of the vaccine, and antiviral immune response
of the African wild dogs.
Conservation of endangered species, both free-living and
captive, has been jeopardized by infectious disease outbreaks
in the past (10). This outbreak of canine distemper illustrates
the disastrous effects that such a disease can have on inade-
quately protected animals. We therefore conclude that any fur-
ther attempts to breed African wild dogs in captivity will need
to ensure a vaccination regime against canine distemper and
other infectious diseases that is both effective in this species
and practical to implement under field conditions.
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Figure 1. Lung lesions in an African wild dog with canine distemper.
Hematoxylin and eosin staining. A. Bronchiole occluded by inflamma-
tory cells and cell debris. B. Detail of A, showing multiple eosinophilic
intracytoplasmic viral inclusions (arrows) in bronchiolar epithelium.
Figure 2. Phylogenetic trees based on a 388-bp Morbillivirus P-gene
fragment. Maximum likelihood trees were generated by using the SEQ-
BOOT and DNAML program of PHYLIP (Phylogeny Inference Package
[6]) with 1,000 bootstrap replications. When possible, GenBank num-
bers of the sequences are given in parentheses. A. Virus from African
wild dogs and representative Morbillivirus members. MV = Measles
virus (Edmonston): strain (M89920); RPV = Rinderpest virus: RBOK
strain (X68311); DMV = dolphin morbillivirus (Z47758); PMV = porpoise
morbillivirus (5); PDV = Phocine distemper virus-1 (X75960); CDV-O =
Canine distemper virus (CDV): Onderstepoort strain (AF305419); and
LP/Tan/01 = CDV African wild dog, Tanzania (this study). B. Virus from
African wild dogs and several CDV strains. CDV-O = CDV: Onderste-
poort strain (AF305419); Dog/Ger/90 = CDV from dog, Germany
(AF259549); Rac/USA/92 = CDV from raccoon, USA (3); Dog/Jap/99 =
CDV from dog, Hamamatsu strain, Japan (AB028915); Dog/Tan/94 =
CDV from dog, Tanzania (U53715); Fox/Tan/94 = CDV from bat-eared
fox, Tanzania (U53714); Lion/Tan/94 = CDV from lion, Tanzania
(U53712); and LP/Tan/01 = CDV from African wild dog, Tanzania (this
study).Emerging Infectious Diseases  •  Vol. 8, No. 2, February 2002 213
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